Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 2013. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of director share transactions rather than a financial performance report.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The only reported change is a charitable donation of 1,000 Ordinary Shares by Director Sir Andrew Witty to Save The Children on May 16, 2013.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risks, contingencies, or unusual items. It strictly details the notification of the director's share transaction in accordance with Disclosure Rule 3.1.4R(1)(a) and (c).
Investor Verification Points
- Confirm the date of the director transaction (May 16, 2013) and the recipient of the donation (Save The Children).
- Verify the identity of the director involved (Sir Andrew Witty) and the number of shares donated (1,000).
- Note that this filing does not contain financial performance data; refer to Form 20-F for comprehensive financial metrics.